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Abstract
The actions of two organic mercurial compounds, 4-(chloromercuri)phenyl-sulfonic acid (4-CMPS) and p-chloromercuri-
benzoic acid (p-CMB) on the calcium release channel (ryanodine receptor) from rabbit skeletal muscle were determined by
single channel recordings with the purified calcium release channel, radioligand binding to sarcoplasmic reticulum vesicles
(HSR) and calcium release from HSR. p-CMB or 4-CMPS (20^100 WM) increased the mean open probability (Po) of the
calcium channel at subactivating (20 nM), maximally activating (20^100 WM) and inhibitory (1^4 mM) Ca2 concentrations,
with no effect on unitary conductance. This activation was partly reversed by 2 mM DTT. Both compounds affected the
channels only from the cytosolic side, but not from the trans side. 100 WM 4-CMPS caused a transient increase in Po,
followed by a low activity state within 1 min. At inhibitory Ca2 concentrations Po was increased to values observed with
maximally activating Ca2 or lower, inhibitory Ca2 concentrations. The p-CMB/4-CMPS modified channels were
ryanodine sensitive and blocked by ruthenium red. [3H]Ryanodine binding was increased up to four-fold with 3^15 WM
4-CMPS/p-CMB (Hill coefficient 1.7^2.0) at 4 WM Ca2 and reduced at high concentrations (50^200 WM). The increase in
[3H]ryanodine binding by 10 WM 4-CMPS was completely inhibited by 2 mM DTT. 4-CMPS significantly increased the
affinity for the high affinity calcium activation sites and decreased the affinity of low affinity calcium inhibitory sites of
specific [3H]ryanodine binding. 4-CMPS increased the affinity of the ryanodine receptor for high affinity ryanodine binding
without a change in receptor density. 4-CMPS induced a rapid, concentration-dependent, biphasic calcium release from
passively calcium-loaded HSR vesicles at subactivating Ca2 concentrations (20 nM), which was partly inhibited by 4 mM
DTT and completely blocked by 20 WM ruthenium red. It is suggested that the 4-CMPS-induced modulation of essential
sulfhydryls involved in the gating of the calcium release channel results in a modulation of the apparent calcium affinity of
the activating high affinity and inhibitory low affinity calcium binding sites of the calcium release channel. 0167-4889 / 98 / $
^ see front matter ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Calcium release from the sarcoplasmic reticulum
(HSR) initiates muscle contraction in skeletal muscle
[1^3]. Calcium release occurs via the ryanodine re-
ceptor-calcium release channel [4^6] which is a tetra-
meric complex containing four identical subunits
with a molecular weight of 565 232 [7] or 564 292
[8] in rabbit skeletal muscle.
The calcium release channel is a¡ected by various
endogenous e¡ectors such as calcium, magnesium,
adenine nucleotides, calmodulin, FK506 binding pro-
tein, as well as phosphorylation [9^12]. Furthermore
a variety of exogenous substances are modulators of
the calcium release channel [12,13].
Modulation of the calcium release channel (ryano-
dine receptor) of skeletal muscle sarcoplasmic retic-
ulum vesicles (HSR) by sulfhydryl-reacting com-
pounds has been demonstrated following oxidation,
irreversible alkylation or nitrosylation of sulfhydryl
groups [14^18]. Organic sulfhydryl-reacting agents
such as p-chloromercuribenzoate (p-CMB) were re-
ported to release calcium and induce contracture in
mechanically skinned ¢bers of frog skeletal muscle
[19] and to release calcium from HSR vesicles of
rabbit skeletal muscle [20]. Oba et al. [21] demon-
strated that 4-CMPS modi¢ed the gating of the cal-
cium release channel of HSR in frog skeletal muscle,
causing an increase in the open probability in single
channel recordings at activating calcium concentra-
tions. The mercury compound thimerosal stimulated
ruthenium red-insensitive calcium release and single
channel activity of rabbit skeletal muscle HSR at
activating calcium concentrations, but inhibited
[3H]ryanodine binding and had no e¡ect on the cal-
cium dependence of [3H]ryanodine binding [22]. On
the other hand, the sulfhydryl alkylating coumaryl
maleimide was reported to inhibit calcium-induced
calcium release from rabbit HSR vesicles and to in-
hibit single channel £uctuations from HSR vesicles
[23], whilst N-ethylmaleimide was recently shown to
activate the calcium release channel in single channel
recordings at high concentrations [17].
In the present study, single channel recordings
with the puri¢ed calcium release channel from rabbit
skeletal muscle revealed channel activation and cal-
cium release from HSR by two organic mercury
compounds (p-CMB and 4-CMPS) at subactivating
free calcium concentrations. This ca¡eine-like e¡ect,
not described for the sulfhydryl-reacting agents
4-CMPS, thimerosal or N-ethylmaleimide, prompted
us to investigate further the role of reactive sulfhyd-
ryl groups of the puri¢ed calcium release channel in
controlling of channel activity and [3H]ryanodine
binding to HSR. This report demonstrates that the
p-CMB- or 4-CMPS-induced mercaptide formation
caused an increase or decrease, depending on the
concentration, in the open probability of the puri¢ed
calcium release channel reconstituted in lipid bilayers
and in [3H]ryanodine binding to HSR. The activating
e¡ect of the mercury compounds was associated with
a modulation of the apparent Ca2 a⁄nity of the
activating high a⁄nity calcium binding sites and in-
hibitory low a⁄nity calcium binding sites of the cal-
cium release channel.
2. Materials and methods
2.1. Materials
p-Chloromercuribenzoic acid, 4-(chloromercuri)-
phenyl-sulfonic acid, p-chlorobenzoic acid, MOPS,
HEPES, Tris, histidine, ATP, CsCl (ultra-pure), caf-
feine, ruthenium red, leupeptin, pepstatin, phenylme-
thylsulfonyl £uoride were purchased from Sigma-
Aldrich GmbH (Vienna); [3H]ryanodine from Du-
pont New England Nuclear (Boston, MA); ryano-
dine from Agrisystems International (Wind Gap);
45CaCl2 from Amersham International (Amersham);
phosphatidylserine, phosphatidylethanolamine and
phosphatidylcholine from Avanti Polar Lipids
(Alabaster, AL); Delrin bilayer chambers (CD22-
200; CD13-200) from Warner Instruments (Hamden,
NJ). Aprotinin was a generous gift from Bayer Aus-
tria AG (Vienna). p-Chloromercuribenzoic acid was
dissolved in methanol, all other agents were dissolved
in MilliQ deionized water.
2.2. Preparation of sarcoplasmic reticulum
HSR vesicles from rabbit skeletal muscle were pre-
pared by a slight modi¢cation of the preparation
described previously [24]. Brie£y, white back muscle
(fast twitch muscle) was homogenized in a Waring
blender for 1.5 min in a medium containing 10 mM
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histidine bu¡er (pH 7.0) and 100 mM NaCl, and
centrifuged for 35 min at 4000Ug. The supernatant
was ¢ltered through cheesecloth and centrifuged
for 30 min at 30 000Ug. The pellet was resuspended
in 10 mM histidine bu¡er (pH 7.0), 0.6 M KCl,
250 mM sucrose and centrifuged for 35 min at
100 000Ug. The pellet was washed once in a medium
containing 10 mM histidine bu¡er (pH 7.0), 100 mM
NaCl, 200 mM sucrose, centrifuged again for 35 min
at 100 000Ug and stored at 380‡C or used immedi-
ately for the puri¢cation of the ryanodine receptor-
calcium release channel. All bu¡ers used for the
preparation and resuspension of HSR contained
0.5 Wg/ml leupeptin, 1 Wg/ml antipain, 1.4 Wg/ml
aprotinin, 1 WM pepstatin, 0.1 mM PMSF, 1 mM
benzamidine.
2.3. Preparation of ryanodine receptor-calcium release
channel
The ryanodine receptor-calcium release channel of
the terminal cysternae of sarcoplasmic reticulum
vesicles was prepared by a slight modi¢cation of
the preparation described previously [24]. Brie£y,
HSR vesicles from rabbit skeletal muscle (prepared
as above) were solubilized with CHAPS (medium:
40 mM MOPS/Tris (pH 7.0), 1 M NaCl, 2 mM
DTT, 1% CHAPS, 0.25% phosphatidylcholine,
0.5 Wg/ml leupeptin, 1 Wg/ml antipain, 1.4 Wg/ml
aprotinin, 1 WM pepstatin, 0.1 mM PMSF, 1 mM
benzamidine, 15 mg HSR/ml; incubation: 60 min
at 3^4‡C), followed by centrifugation twice for
35 min at 103 000Ug (Beckman 65 rotor). The super-
natant was centrifuged through a linear 7.5^20% su-
crose gradient equilibrated in 40 mM MOPS/Tris
(pH 7.0), 300 mM NaCl, 2 mM DTT, 0.5% CHAPS,
0.25% phosphatidylcholine, 0.5 Wg/ml leupeptin, 1
Wg/ml antipain, 1.4 Wg/ml aprotinin, 1 WM pepstatin,
0.1 mM PMSF, 1 mM benzamidine for 14 h at 2‡C
(Beckman SW28 rotor; 38 ml tubes). Fractions
containing the ryanodine receptor (determined by
SDS-PAGE) were pooled and dialysed for 22^24 h
in a medium containing 40 mM MOPS/Tris (pH 7.0),
100 mM NaCl, 2 mM DTT, 0.15 mM CaCl2, 0.1 mM
EGTA, 0.5 Wg/ml leupeptin, 1 Wg/ml antipain, 1.4
Wg/ml aprotinin, 1 WM pepstatin, 0.1 mM PMSF,
1 mM benzamidine. Sucrose (200 mM ¢nal concen-
tration) was added to the proteoliposomes before
storage at 380‡C. Preparation and dialysis were car-
ried out at 2^4‡C.
2.4. SDS-polyacrylamide gel electrophoresis
(SDS-PAGE)
SDS-PAGE was performed in 7% or 12% poly-
acrylamide gels (0.75 mm thickness) with 3% stack-
ing gels, according to Laemmli [25]. Samples were
incubated for 5 min in boiling water in 2% SDS,
2% mercaptoethanol, 10% glycerol and 10 mM Tris
(pH 6.8). Gels were stained with 0.05% Coomassie
blue in 10% acetic acid. Molecular weight standards
were always run on two separate lanes of the same
gel: thyroglobulin (330 000), myosin (212 000), K2-
macroglobulin (170 000), bovine serum albumin
(68 000), catalase (60 000), glutamic dehydrogenase
(53 000), ovalbumin (43 000), lactate dehydrogenase
(36 000), carbonic anhydrase (30 000) and myoglobin
(16 900).
2.5. [3H]Ryanodine binding
Test samples and controls were assayed in dupli-
cate or triplicate for 90 min at 37‡C in 0.1 or 0.2 ml
solution containing 20 mM MOPS/Tris (pH 7.0), 1 M
NaCl, 0.1 or 0.2 mg HSR, 0.5 Wg/ml leupeptin,
1.4 Wg/ml aprotinin, 0.1 mM PMSF, 0.3^300 nM
[3H]ryanodine, 0.5 mM EGTA plus di¡erent con-
centrations of CaCl2 at free calcium concentrations
6 10 WM or zero EGTA, plus CaCl2 at free calcium
concentration s 100 WM. 4-CMPS was present at
concentrations of 1^200 WM and p-CMB at concen-
trations of 1^30 WM (see legends to the ¢gures). Sam-
ples were ¢ltered on glass-¢ber ¢lters (presoaked in
1% polyethylene imine) and washed 3 times with 5 ml
of 20 mM MOPS/Tris (pH 7.0), 1 M NaCl. Non-
speci¢c binding was measured in the presence of
50^100 WM unlabeled ryanodine.
2.6. Calcium release from passively loaded
sarcoplasmic reticulum
Calcium release from HSR vesicles was determined
by a Bio-Logic rapid-¢ltration system [26] as de-
scribed previously [27]. Brie£y, HSR vesicles were
passively loaded with calcium by incubation for 24^
48 h on ice in a medium containing 40 mM MOPS/
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Tris (pH 7.0), 150 mM KCl, 10 mM 45CaCl2, 10
mg/ml HSR, 0.5 Wg/ml leupeptin, 1 Wg/ml antipain,
1.4 Wg/ml aprotinin, 1 WM pepstatin, 0.1 mM
PMSF, 1 mM benzamidine. The passively loaded
vesicles were diluted 100-fold in a medium containing
40 mM MOPS/Tris (pH 7.0), 150 mM KCl, 2 mM
EGTA, 5 mM MgCl2, giving a ¢nal concentration of
0.1 mg/ml HSR, with 0.1 mM 45CaCl2 present as
contaminant. 1 ml of the diluted vesicle solution
was applied to a Millipore ¢lter (0.65 Wm pore
size). The release medium contained 40 mM
MOPS/Tris (pH 7.0), 150 mM KCl, 2 mM EGTA
plus 0.185 mM CaCl2 (free Ca2 about 20 nM) and
10^100 WM 4-CMPS, T = 25^27‡C.
2.7. Single channel recordings
Single channel recordings were carried out follow-
ing incorporation of puri¢ed calcium release chan-
nels (ryanodine receptors) into planar lipid bilayers,
essentially according to Coronado et al. [28]. Planar
lipid bilayers were formed from phosphatidylserine
(10 mg/ml) and phosphatidylethanolamine (10
mg/ml) in decane (Avanti Polar Lipids). The lipid
solution was spread over a 200 Wm diameter aperture
in a delrin cup (Warner Instruments) separating two
aqueous compartments. The cis bath (2.6 ml) and the
trans bath (4 ml) were connected to the head stage
input of a model EPC-9 ampli¢er (Heka Elektronik,
Lambrecht, Germany). The trans bath was held on
virtual ground. CsCl was used as the charge carrier
through the calcium release channel to increase the
conductance of the [28]. The cis solution was com-
posed of 10 mM HEPES/Tris (pH 7.4), 480 mM
CsCl, and 100 WM CaCl2 or 100 WM CaCl2 plus
80 WM EGTA (free calcium 20 WM). The trans solu-
tion was composed of 10 mM HEPES/Tris (pH 7.4)
and 50 mM CsCl and in some experiments, addition-
ally 100 WM CaCl2 or 100 WM CaCl2 plus 80 WM
EGTA (free calcium 20 WM). Unless stated other-
wise, puri¢ed calcium release channels (1.5^2.0
Wg/ml) and other reagents were added to the cis
chamber. Recordings were ¢ltered at 4 kHz (in a
C
Fig. 1. E¡ect of p-CMB on a single puri¢ed skeletal muscle cal-
cium release channel at a subactivating calcium concentration
of 20 nM Ca2. Single channel currents, shown as upward de-
£ections, were recorded at 0 mV holding potential with 480
mM/50 mM CsCl (cis/trans). The baselines are indicated by the
solid lines. Control and test records (A^F) are from the same
channel. (A) Control (20 WM Ca2), Po = 0.28. (B) Inactivation
of the channel by addition of EGTA (20 nM Ca2), Po6 0.001.
(C) Activation of the channel by 30 WM p-CMB added to the
cis side at 20 nM Ca2, Po = 0.21. (D) 3.6 WM ryanodine. (E)
10 WM ruthenium red. The calibration bars represent 50 pA
and 5 ms and 10 ms. Single channel current-voltage relationship
for a skeletal muscle calcium release channel activated by 20 WM
calcium and 30 WM p-CMB in the presence of 20 nM calcium
on the cytosolic site of the bilayer. Equilibrium potential and
slope conductances are indicated in the inset.
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few experiments at 6 kHz) with a low-pass Bessel
¢lter, digitized at 40 kHz and stored on the hard
disk of a McIntosh/PC. Single channel events were
identi¢ed using TAC V2.5 software (Skalar Instru-
ments, Seattle, WA). Mean open probability (Po) of
channels and life time of open and closed events were
identi¢ed by a 50% threshold analysis.
2.8. Protein assay
Protein was measured by the Folin method [29]
and in the presence of detergents plus phosphatidyl-
choline, according to Kaplan and Pedersen [30],
standardized against bovine serum albumin.
2.9. Calculations
Curve ¢tting was carried out using the standard
Maquart-Levenberg algorithm provided by Sigma-
plot 2 (Jandel, San Rafael, CA) or Figure P (Biosoft,
Cambridge, UK). Statistical analysis was carried out
by t-test using Sigmastat 2 software (Jandel, San Ra-
fael, CA). Averaged results are presented as means
þ S.E.M.
3. Results
3.1. Activation of the calcium release channel by
p-CMB or 4-CMPS in the presence of
subactivating calcium concentrations [20 nM]
In all single channel experiments current £uctua-
tions of a single puri¢ed skeletal muscle SR calcium
release channel were ¢rst recorded in a 50^480 mM
CsCl gradient at 20 WM free calcium and 0 mV hold-
ing potential. Under these conditions, channel open
probability was in the range of 0.25^0.72 as deter-
mined with di¡erent channels from more than 20
channel preparations. The best ¢t to the open and
closed life time distribution was obtained by two ex-
ponentials.
An example of the e¡ect of p-CMB on the puri¢ed
calcium release channel at subactivating calcium con-
centrations is illustrated in Fig. 1. Channel open
probability (Po) of the control at 20 WM Ca2 was
0.28. When the free calcium concentration on the cis
side of the bilayer was reduced to 20 nM by addition
of EGTA the calcium release channels were practi-
cally closed (Po6 0.001; Fig. 1B). The addition of 30
WM p-CMB to the solution on the cis side activated
the channel within a few minutes, with Po increasing
from 6 0.001 to 0.21 (Fig. 1C). The p-CMB-acti-
vated channel was ryanodine sensitive and blocked
by ruthenium red (Fig. 1D,E). 3.6 WM ryanodine
added to the cis side induced an open-locked sub-
state, with a reduction of the current amplitude
from 33.3 pA to 17.9 pA. The reduction of the chan-
nel amplitude by about 50% strongly indicates that
channel activation is due to the activation of a single
channel [31,32]. A further addition of 10 WM ruthe-
Fig. 2. E¡ect of 4-CMPS on a single puri¢ed skeletal muscle
calcium release channel at a subactivating calcium concentra-
tion of 20 nM Ca2. Single channel currents, shown as upward
de£ections, were recorded at 0 mV holding potential with 480
mM/50 mM CsCl (cis/trans). The baselines are indicated by the
solid lines. Control and test records (A^D) are from the same
channel. (A) Control (20 WM Ca2), Po = 0.43. (B) Inactivation
of the channel by addition of EGTA (20 nM Ca2), Po6 0.001.
(C) Po increased to 0.14 in the presence of 100 WM 4-CMPS
added to the cis side at 20 nM Ca2 (1 min). (D) Po was re-
duced by 2 mM DTT. The calibration bars represent 50 pA
and 5 ms.
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nium red to the cis side closed the calcium release
channel (Fig. 1E). Current voltage curves in Fig. 1F
are for the open state for the preceding control peri-
od at 20 WM free calcium and for the open state
induced in the same channel by 30 WM p-CMB in
the presence of 20 nM free calcium. p-CMB had no
e¡ect on the conductance of the calcium release
channel. The slope conductance was 571 pS in the
absence of p-CMB and 564 pS in the presence of
30 WM p-CMB at 20 nM free calcium. The single
channel reversal potentials for the control and the
4-CMB-induced channels was 359 mV and 358
mV, which is close to the cesium equilibrium poten-
tial (357.8 mV).
Statistical analysis of three experiments with
p-CMB showed that the open probability in the pres-
ence of 20 nM free calcium increased from 6 0.001
to 0.23 þ 0.02 (n = 3; S.E.M.); the open probability
Fig. 3. E¡ect of 20 WM 4-CMPS on single puri¢ed skeletal muscle calcium release channels at 20 WM activating calcium. Single chan-
nel currents, shown as upward de£ections, were recorded at 0 mV holding potential with 480 mM/50 mM CsCl (cis/trans). The base-
lines are indicated by the solid lines. Control and test records (A^E) are from the same channel. (A) Control: 20 WM Ca2 (100 WM
CaCl2+80 WM EGTA), Po = 0.66. (B) Activation of the channel by 20 WM 4-CMPS added to the cis side, 20 WM Ca2, Po=0.92. Life
time histograms of open times and channel opening time constants (do) of control and 4-CMPS-modi¢ed channel are displayed in
panels C and D, respectively. The solid lines represent the ¢t according to two or three exponentials. Channel open probabilities (Po)
and do were calculated from 18 344 events (control) and 6869 events (4-CMPS), respectively. Calibration bars represent 50 pA and 50
ms. (E) Single channel current-voltage relationship for a skeletal muscle calcium release channel activated by 20 WM Ca2 and 20 WM
4-CMPS in the presence of 20 WM Ca2 on the cytosolic site of the bilayer. Equilibrium potential and slope conductances are indi-
cated in the inset.
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of the same channels in the presence of 20 WM Ca
were 0.41 þ 0.07 (n = 3; S.E.M.; range 0.28^0.52).
The conductance of the open state during the control
period in the presence of 20 WM free calcium and the
conductance of the p-CMB-induced open state in the
presence of 20 nM free calcium was not signi¢cantly
di¡erent (596 þ 39 pS versus 579 þ 33 pS; n = 3;
means þ S.E.M.).
A similar, activating e¡ect on the puri¢ed calcium
release channel at subactivating calcium concentra-
tions was observed with 4-CMPS. In all experiments
with higher concentrations of organic mercurial com-
pounds only 4-CMPS was used, since it is readily
soluble in water at a concentration of 10 mM. 100
WM 4-CMPS added to the cis side at 20 nM Ca2
activated the calcium release channels (Fig. 2). Po
increased over a period of about 1 min after addition
of the drug from 6 0.001 to 0.14 (Fig. 2C). This
activating e¡ect was markedly reduced by addition
of 2 mM DTT added to the cis side (Fig. 2D). The
channel activation at these low subactivating calcium
concentrations and its inhibition by DTT agree
closely with the rapid, ruthenium red- and DTT-sen-
sitive 4-CMPS-induced calcium e¥ux from HSR
vesicles at 20 nM free calcium (see below).
3.2. E¡ect of p-CMB and 4-CMPS on the calcium
release channel at activating [20^100 WM]
calcium concentrations
10^20 WM 4-CMPS activated the calcium release
channel in the presence of maximally activating cal-
cium concentrations of 20^100 WM free calcium. In
the experiment illustrated in Fig. 3 the open proba-
bility was increased from 0.66 to 0.92 by 20 WM
4-CMPS added to the cis side in the presence of
20 WM Ca2 (Fig. 3A,B), whilst the conductance of
the 4-CMPS-modi¢ed channel, determined from the
same channel, was not a¡ected (control: 559 pS;
4-CMPS: 547 pS) (Fig. 3E). Means of Po, current
amplitudes and the distribution of the open and
closed life times of controls and of the same channels
modi¢ed by 20 WM 4-CMPS in seven experiments are
given in Table 1. The increase in the open probability
(control: 0.43 þ 0.05; 4-CMPS: 0.88 þ 0.01; n = 7;
Table 1A) was associated with an increase of the
open life times of the 4-CMPS modi¢ed channel
and the best ¢t was obtained by three exponentials
(control: do1 = 0.22 þ 0.02 ms (70%); do2 = 0.54 þ 0.08
ms (30%); 4-CMPS: do1 = 0.24 þ 0.06 ms (28%);
do2 = 1.52 þ 0.22 ms (64%); do3 = 5.56 þ 1.06 ms
(14%), Fig. 3C,D; Table 1, n = 7, means þ S.E.M.).
The channel activation by 20 WM 4-CMPS was
partially reversed by addition of 2 mM DTT (Fig.
4), which strongly indicates that the activating e¡ect
of 4-CMPS is due to a modulation of sulfhydryl
groups essential for the gating of the calcium release
channel. 2 mM DTT had no e¡ect on Po in controls.
In ¢ve experiments, carried out at conditions given in
Fig. 4 (100 WM Ca2), the open probability was
0.62 þ 0.04 in controls and 0.64 þ 0.06 in the presence
of 2 mM DTT (n = 5; means þ S.E.M.). DTT had
Table 1
Mean open and closed channel lifetimes of controls and after stimulation by 20 WM 4-CMPS (A) and 20 WM p-CMB (B)
Treatment Po do (ms), weight (%) dc (ms), weight (%) Amplitude (pA)
(A) Control (n = 7) 0.43 þ 0.05 do1 0.22 þ 0.02 (70) dc1 0.38 þ 0.04 (94) 30.1 þ 2.2
do2 0.54 þ 0.08 (30) dc2 1.38 þ 0.14 (5)
20 WM 4-CMPS (n = 7) 0.88 þ 0.01 do1 0.24 þ 0.06 (28) dc1 0.11 þ 0.01 (99) 28.1 þ 1.8
do2 1.52 þ 0.22 (64)
do3 5.56 þ 1.06 (14)
(B) Control (n = 4) 0.56 þ 0.05 do1 0.27 þ 0.08 (62) dc1 0.26 þ 0.04 (90)
do2 0.86 þ 0.24 (38) dc2 1.59 þ 0.89 (10)
20 WM p-CMB (n = 4) 0.87 þ 0.03 do1 0.20 þ 0.02 (23) dc1 0.17 þ 0.02 (99)
do2 1.64 þ 0.58 (54)
do3 4.85 þ 1.68 (22)
Channel open probabilities (Po), cumulative mean open and closed channel time constants (do, dc) and values of the percent of the
channel represented by a time constant for puri¢ed calcium release channel activated by 20 WM cis Ca2 in the absence or presence of
20 WM 4-CMPS (A) of 20 WM p-CMB (B). Values given are means þ S.E.M. from seven (A) or four (B) channels included in the anal-
ysis. Calcium release channels were recorded at 0 mV voltage holding potential with 480 mM/50 mM CsCl (cis/trans).
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also no e¡ect on channel current and Po in controls
at concentrations of 4 mM (n = 3) or 8 mM DTT
(n = 2), which is not be expected, since DTT was
used in the preparation of the calcium release chan-
nel.
With high concentrations of 4-CMPS (100 WM)
added to the cis side at 20^100 WM Ca2 a fast,
transient activation of the calcium release channels,
with an increase of the open probability, occurred
over a period of less than 1 min (control:
Po = 0.52; 4-CMPS: Po = 0.91), followed by a
marked inhibition of the channel activity (Po = 0.02)
(Fig. 5). In ¢ve experiments 100 WM 4-CMPS added
to the cis side in the presence of 20 WM free calcium
reduced the open probability from 0.65 þ 0.03 (con-
trol; n = 5, S.E.M.) to 0.06 þ 0.01 (4-CMPS; n = 5,
S.E.M.). The open life times of the 4-CMPS-inhib-
ited channels were scarcely a¡ected by 4-CMPS (con-
trol: do1 = 0.46 þ 0.06 ms (71%); do2 = 1.41 þ 0.27 ms
(29%); 4-CMPS: do1 = 0.38 þ 0.12 ms (79%); do2 =
1.54 þ 0.48 ms (21%); n = 5, means þ S.E.M.), whilst
the closed life times were markedly prolonged (con-
trol: dc1 = 0.25 þ 0.03 ms (98%) and dc2 = 4.55 þ 2.09
ms (2%); 4-CMPS: dc1 = 1.29 þ 0.61 ms (39%) and
dc2 = 9.57 þ 2.42 ms (61%); n = 5, means þ S.E.M.).
To test the sidedness and concentration depend-
ence of the inhibitory 4-CMPS e¡ect, current £uctu-
ations of a single skeletal muscle SR calcium release
channel in the presence of 20 WM free calcium were
determined under the following conditions: (a) con-
trol; (b) trans only 4-CMPS; (c) 4-CMPS (trans and
cis) (Fig. 6). 100^200 WM 4-CMPS added to the trans
side had little or no e¡ect on current £uctuations.
Fig. 5. E¡ect of high concentrations of 4-CMPS on single puri-
¢ed skeletal muscle calcium release channels at 20 WM activat-
ing calcium. Single channel currents, shown as upward de£ec-
tions, were recorded at 0 mV holding potential with 480 mM/
50 mM CsCl (cis/trans). The baselines are indicated by the solid
lines. Control and test records are from the same channel. (A)
Control (20 WM Ca2). (B) 4-CMPS modi¢ed channel 1 min
and 4 min after addition of 100 WM 4-CMPS to the cis side.
Calibration bars represent 50 pA and 5 ms.
Fig. 4. Reversibility of the 4-CMPS e¡ect on single puri¢ed
skeletal muscle calcium release channel at 100 WM activating
calcium by DTT. Single channel currents, shown as upward de-
£ections, were recorded at 0 mV holding potential with 480
mM/50 mM CsCl (cis/trans). The baselines are indicated by the
solid lines. Control and test records are from the same channel.
(A) Control (100 WM Ca2), Po = 0.36. (B) 4-CMPS modi¢ed
channel (20 WM added to the cis side), Po = 0.88. (C) 2 mM
DTT added to the cis side reduced Po from 0.88 to 0.47. (D) 2
WM ryanodine added to the cis side. Channel open probabilities
(Po) were calculated from 15 500 events (control), 14 989 events
(4-CMPS) and 18 532 events (DTT). Calibration bars represent
50 pA and 5 ms.
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Addition of 140 WM 4-CMPS to the cis side caused a
marked reduction of the open probability of the cal-
cium channels from 0.56 to 0.02 and a small reduc-
tion in the current amplitude (16%). Increasing the 4-
CMPS concentration to 420 WM caused a marked
reduction of the current amplitude (56%); however,
a full blockade of the calcium release channel was
not obtained at this high concentration (Fig. 6).
This e¡ect is currently being investigated in more
detail.
The activating e¡ect of p-CMB on the calcium
release channel at 20 WM activating calcium was
practically the same as that observed with 4-CMPS.
p-CMB added to the cis side increased the open
probability of the calcium release channel from
0.56 þ 0.05 in the absence of the compound to
0.87 þ 0.03 in the presence of 20 WM p-CMB
(n = 4). Furthermore, the increases in the open time
constants by 20 WM p-CMB or 20 WM 4-CMPS were
similar (Table 1A,B), i.e. both compounds induced a
nearly full open state of the calcium release channel,
which was not observed in the presence of calcium as
the sole activating ligand. p-CMB and 4-CMPS di¡er
in their solubility in water and lipid solubility.
Although the negatively charged sulfonic acid group
in the case of 4-CMPS reduces the lipid solubility as
compared to p-CMB [33], both compounds appear to
react with the same sulfhydryl groups. High concen-
Fig. 7. E¡ect of 4-CMPS on single puri¢ed skeletal muscle cal-
cium release channels at inhibitory Ca2. Single channel cur-
rents, shown as upward de£ections, were recorded at 0 mV
holding potential with 480 mM/50 mM CsCl (cis/trans). The
baselines are indicated by the solid lines. Recordings A^C are
from the same channel. (A) Control (100 WM Ca2). (B) Inhibi-
tion by 1 mM Ca2. (C) Activation by 20 WM 4-CMPS added
to the cis side at 1 mM Ca. Calibration bars represent 50 pA
and 5 ms.
Fig. 6. Sidedness of 4-CMPS on single puri¢ed skeletal muscle
calcium release channels at 20 WM activating calcium. Single
channel currents, shown as upward de£ections, were recorded
at 0 mV holding potential with 480 mM/50 mM CsCl (cis/
trans). The baselines are indicated by the solid lines. Recordings
A^D are from the same channel. (A) Control (20 WM Ca2
cis). (B) 100 WM 4-CMPS trans. (C) Plus 140 WM 4-CMPS cis.
(D) Plus 280 WM 4-CMPS cis (total 420 WM). Calibration bars
represent 50 pA and 5 or 15 ms.
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trations of p-CMB (i.e. 100 WM) were not used to
avoid methanol concentrations above 1%.
3.3. E¡ect of 4-CMPS at inhibitory calcium
concentrations
4-CMPS activated the calcium release channel also
at inhibitory calcium concentrations (1^4 mM). 20
WM 4-CMPS increased the open probability in the
presence of 1 mM free calcium from 0.15 þ 0.01 to
0.55 þ 0.12 (n = 3; means þ S.E.M.; Fig. 7); the open
probability of the same channels in the presence of
100 WM Ca2 was 0.54 þ 0.06 (n = 3; means
þ S.E.M.). At 4 mM Ca2, low concentrations of
4-CMPS (20^40 WM) increased the open probability
to levels observed with about 2 mM Ca2 in con-
trols, in the absence of the compound.
3.4. E¡ect of p-CMB and 4-CMPS on [3H]ryanodine
binding
[3H]Ryanodine binding was carried out with HSR
vesicles in 90 min assays at 37‡C in the presence of 1
M NaCl, [3H]ryanodine concentrations from 0.3 to
300 nM and free calcium concentrations ranging
from 0.01 WM to 40 mM. p-CMB and 4-CMPS
showed a complex e¡ect on [3H]ryanodine binding.
An increase in [3H]ryanodine binding was observed
at low concentrations of both substances, whilst high
concentrations reduced [3H]ryanodine binding.
The concentration dependence of 4-CMPS and
p-CMB on [3H]ryanodine binding (performed with
12 nM [3H]ryanodine at 4 WM free calcium and in
the presence of 1 M NaCl) showed that both sub-
Fig. 9. Stimulation of [3H]ryanodine binding by 4-CMPS in the
presence of 1 M NaCl. Speci¢c [3H]ryanodine binding was per-
formed in the absence (a) or presence of 10 WM 4-CMPS (R).
Solid lines represent a ¢t using a single binding site isotherm.
Fitted parameters were Bmax = 12.09 þ 0.58 pmol/mg and
Kd = 45.4 þ 7.77 nM (control ; means þ S.E.M.; n = 3); Bmax =
12.20 þ 0.48 pmol/mg and Kd 11.24 þ 1.64 nM (4-CMPS; means
þ S.E.M.; n = 3).
Table 2
E¡ect of 4-CMPS and/or ca¡eine on [3H]ryanodine binding in
the presence of 1 M NaCl
[3H]Ryanodine bound
(pmol/mg HSR)
Control 1.57 þ 0.21
10 WM 4-CMPS 5.09 þ 0.48
100 WM 4-CMPS 1.02 þ 0.19
200 WM 4-CMPS 1.18 þ 0.07
10 mM Ca¡eine 5.02 þ 0.31
10 mM Ca¡eine+10 WM 4-CMPS 6.98 þ 0.75
10 mM Ca¡eine+100 WM 4-CMPS 1.01 þ 0.07
Speci¢c [3H]ryanodine binding was performed in the absence or
presence of 10 WM 4-CMPS, 10 mM ca¡eine, 10 WM 4-CMPS
plus 10 mM ca¡eine, and 100^200 WM 4-CMPS. Medium: 20
mM MOPS/Tris (pH 7.0), 1 M NaCl, 0.1 mg HSR, 0.5 Wg/ml
leupeptin, 1.4 Wg/ml aprotinin, 0.1 mM PMSF, 12 nM
[3H]ryanodine, 0.5 mM EGTA, 0.475 WM CaCl2 (free calcium
4 WM); 90 min, 37‡C. Values are means þ S.E.M. from three ex-
periments.
Fig. 8. Concentration dependence of stimulation of
[3H]ryanodine binding by 4-CMPS and p-CMB in the presence
of 1 M NaCl and 4 WM Ca2. Speci¢c [3H]ryanodine binding
was performed with 12 nM [3H]ryanodine in the presence of
the indicated concentrations of 4-CMPS (R) and p-CMB (O).
The solid line represents a ¢t of the data according to the Hill
equation. Control binding was 1.16 pmol/mg (for 4-CMPS) and
1.30 pmol/mg (for p-CMB) in the presence of 1.5% methanol.
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stances increased the speci¢c [3H]ryanodine binding
dose-dependently at concentrations between 1 and
10^15 WM; the maximum amount of [3H]ryanodine
bound was 4.0^4.5-fold greater than in the controls;
the Ka values were 2.65 WM and 6.6 WM, respectively
(Fig. 8). The steep increase in [3H]ryanodine binding
and Hill coe⁄cients of 1.7^2.0 indicate that at least
two 4-CMPS or p-CMB molecules bound to the cal-
cium release channel induce the increase in ryanodine
binding. When the 4-CMPS concentrations were in-
creased above 15^20 WM, the stimulatory e¡ect on
[3H]ryanodine binding declined progressively and
was below control levels with 100 WM 4-CMPS, i.e.
high concentrations of 4-CMPS did not activate rya-
nodine binding, but indeed reduced [3H]ryanodine
binding (Table 2).
Fig. 9 shows the e¡ect of 4-CMPS on
[3H]ryanodine binding a⁄nity and ryanodine recep-
tor density of HSR vesicles, carried out in the pres-
ence of 1 M NaCl and a maximally activating cal-
cium concentration (100 WM). 4-CMPS shifted the
[3H]ryanodine binding curve to the left. The appar-
ent dissociation constant (Kd) for [3H]ryanodine de-
creased from 45.4 þ 7.7 nM (control) to 12.09 þ
0.58 nM (means þ S.E.M.; n = 3) in the presence of
10 WM 4-CMPS; maximum [3H]ryanodine binding
(Bmax) remained unchanged (control: 12.20 þ 0.48
pmol/mg HSR; 4-CMPS: 11.24 þ 1.64 pmol/mg
HSR; means þ S.E.M.; n = 3). These data demon-
strate that 4-CMPS increased the a⁄nity of the rya-
nodine receptor for the high a⁄nity ryanodine bind-
ing sites, whilst maximum ryanodine binding
(receptor density) was not signi¢cantly changed.
Fig. 10 shows the calcium dependence of
[3H]ryanodine binding to HSR vesicles in the absence
and presence of 4-CMPS or ca¡eine performed with
12 nM [3H]ryanodine in the presence of 1 M NaCl.
10 WM 4-CMPS shifted the calcium activation curve
to the left, similar to the e¡ect observed with 10 mM
ca¡eine, which was included for comparison. The
apparent Ka values for 4-CMPS (1.18 þ 0.23 WM)
and ca¡eine (0.65 þ 0.09 WM) were signi¢cantly lower
than for controls (4.53 WM þ 0.70) indicating that
4-CMPS and ca¡eine increased the apparent a⁄nity
of the high a⁄nity calcium activation sites (Fig. 10,
Table 3). Inhibition of [3H]ryanodine binding by
high calcium concentrations in the presence of 1 M
NaCl required high calcium concentrations. 10 WM
4-CMPS shifted the calcium inhibition curve to the
right. The apparent Ki value for 4-CMPS
(14 770 þ 1242 WM) was signi¢cantly higher than for
controls (7356 þ 634 WM) indicating that the 4-CMPS
decreases the apparent a⁄nity of the calcium inacti-
vation sites (Fig. 10, Table 3).
10 WM 4-CMPS increased speci¢c [3H]ryanodine
binding at low calcium concentrations, similar to
10 mM ca¡eine (Table 2). The stimulation of speci¢c
[3H]ryanodine binding to HSR vesicles by 10 WM
Table 4
Inhibition of 4-CMPS-induced stimulation of [3H]ryanodine
binding by DTT
[3H]Ryanodine bound (pmol/mg HSR)
Control 1.53 þ 0.15
+2 mM DTT 1.37 þ 0.18
10 WM 4-CMPS 5.46 þ 0.37
+2 mM DTT 1.44 þ 0.19
Speci¢c [3H]ryanodine binding was performed in a medium con-
taining 20 mM MOPS/Tris (pH 7.0), 1 M NaCl, 0.1 mg HSR,
0.5 Wg/ml leupeptin, 1.4 Wg/ml aprotinin, 0.1 mM PMSF, 12
nM [3H]ryanodine, 0.5 mM EGTA, 0.475 WM CaCl2 (free calci-
um 4 WM), zero (control) or 10 WM 4-CMPS in the absence or
presence of 2 mM DTT; 90 min, 37‡C. Values are means
þ S.E.M. from ¢ve experiments with three di¡erent HSR prepa-
rations.
Table 3
Ca2 dependence of [3H]ryanodine binding in the presence of 10 WM 4-CMPS or 10 mM ca¡eine
Control 10 WM 4-CMPS 10 mM ca¡eine
Bmax (pmol/mg) 4.75 þ 0.29 6.54 þ 0.96 5.32 þ 0.69
Ka (Ca) (WM) 4.53 þ 0.70 1.18 þ 0.23* 0.65 þ 0.09*
na 1.76 þ 0.37 2.49 þ 0.36 2.75 þ 0.31
Ki (Ca) (WM) 7356 þ 634 14770 þ 1242* 7728 þ 1191
ni 1.54 þ 0.05 1.42 þ 0.07 1.47 þ 0.12
Maximum [3H]ryanodine binding (Bmax), Ka and Ki values and Hill coe⁄cients (n) were derived from the data given in Fig. 10. Values
are means þ S.E.M. from three experiments. *Signi¢cantly di¡erent from controls (P6 0.01).
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4-CMPS plus 10 mM ca¡eine was additive, demon-
strating that 4-CMPS and ca¡eine bind to di¡erent
sites at the ryanodine receptor. On the other hand,
the ca¡eine-stimulated [3H]ryanodine binding was
abolished in the presence of high concentrations of
4-CMPS (200 WM) (Table 2).
The stimulation of speci¢c [3H]ryanodine binding
to HSR vesicles in the presence of 10 WM 4-CMPS
(carried out with 12 nM [3H]ryanodine and a low
calcium concentration of 4 WM) was abolished by
2 mM DTT. 2 mM DTT had no signi¢cant e¡ect
on control [3H]ryanodine binding (Table 4).
3.5. E¡ect of 4-CMPS on calcium release from HSR
vesicles
The e¡ect of 4-CMPS on the calcium release from
passively loaded HSR vesicles was investigated at
free calcium concentrations of 20 nM in the absence
or presence of 30 WM and 100 WM 4-CMPS. Fig. 11
shows the e¡ect of 100 WM 4-CMPS on the calcium
release from passively loaded HSR vesicles carried
out at a free calcium concentration of 0.02 WM.
Table 5
4-CMPS-induced calcium release from passively loaded HSR vesicles and its inhibition by DTT or ruthenium red
Ca2 released (nmol/mg HSR/5 s)
Control 15.82 þ 1.81 (n = 6)
2 mM EGTA+5 mM MgCl2 2.56 þ 0.69 (n = 6)
30 WM 4-CMPS 45.20 þ 0.85 (n = 3)
100 WM 4-CMPS 58.78 þ 1.19 (n = 6)
100 WM 4-CMPS+4 mM DTT 25.82 þ 1.18 (n = 5)
100 WM 4-CMPS+20 WM ruthenium red 3.30 þ 1.50 (n = 2)
Data are taken from Fig. 11. Values are means þ S.E.M. for the number of determinations given in parentheses.
Fig. 11. 4-CMPS-induced calcium release from passively loaded
HSR vesicles. The calcium release was measured with a rapid
£ow apparatus at 20 nM free calcium, as described in Section
2. Dilution medium: 40 mM MOPS/Tris (pH 7.0), 150 mM
KCl, 2 mM EGTA, 5 mM MgCl2, 0.1 mg/ml HSR, with
0.1 mM 45CaCl2 present as contaminant. The release medium
contained 40 mM MOPS/Tris (pH 7.0), 150 mM KCl, 2 mM
EGTA, 0.185 mM CaCl2 (free Ca2 about 20 nM) in the ab-
sence (b) or presence of 100 WM 4-CMPS (R ; t0:51 = 0.04 s;
t0:52 = 2.3 s) or 100 WM 4-CMPS plus 4 mM DTT (O ;
t0:51 = 0.96 s; t0:52 = 61 s) or 100 WM 4-CMPS plus 20 WM
ruthenium red (S) or 2 mM EGTA plus 5 mM MgCl2 without
added calcium (a). T = 26^27‡C. The calcium load was 98.4
nmol/mg HSR. Values are means of 2^7 determinations.
Fig. 10. E¡ect of 4-CMPS and ca¡eine on calcium dependence
of [3H]ryanodine binding in the presence of 1 M NaCl. Speci¢c
[3H]ryanodine binding was performed with 12 nM
[3H]ryanodine in the absence (a) or presence of 10 WM
4-CMPS (R) or 10 mM ca¡eine (E). The solid lines represent a
¢t of the data according to equation 1 [41]: B = Bmax
Ca2na=Ca2na  Kana 13Ca2ni=Ca2ni  K ini  Bmax =
maximum [3H]ryanodine binding, Ka = Ca2 concentration giv-
ing half-maximum activation, Ki = Ca2 concentration giving
half-maximum inhibition; na and ni = number of activating or
inhibiting calcium species. The calculated parameters are given
in Table 3.
BBAMCR 14350 8-9-98
J. Suko, G. Hellmann / Biochimica et Biophysica Acta 1404 (1998) 435^450446
100 WM 4-CMPS induced a rapid biphasic calcium
release; the half-times for the two phases were 0.04 s
and 2.3 s, respectively. 100 WM 4-CMPS released
about 60% of the calcium load within 5 s and about
70% of the calcium load within 10 s (Fig. 11, Table
5). 30 WM 4-CMPS released about 46% and 60% of
the load within 5 s (Table 5) and 10 s, respectively.
The 4-CMPS-induced calcium release (100 WM) was
completely inhibited by 20 WM ruthenium red added
to the release medium, demonstrating that the calci-
um release occurred via the calcium release channel
of HSR vesicles. 4 mM DTT present in the release
medium markedly reduced the calcium release in-
duced by 100 WM 4-CMPS (Fig. 11; Table 5).
4. Discussion
The e¡ects of p-CMB and 4-CMPS on the ryano-
dine receptor- calcium release channel have been de-
termined by three di¡erent parallel indicators of
channel function, namely by single channel record-
ings with the puri¢ed calcium release channel (rya-
nodine receptor), radioligand binding to HSR and
calcium release from passively calcium-loaded HSR
vesicles. Single channel recordings demonstrate acti-
vation, as well as inhibition of the calcium release
channel by p-CMB or 4-CMPS. The interesting ef-
fect, not reported for the thiol-modulating com-
pounds such as thimerosal [22], N-ethylmaleimide
[17,23] or glutathione disul¢de [16], is the fact that
the agents a¡ect the Ca2 a⁄nity of the high a⁄nity
calcium activation sites as well as the low a⁄nity
inhibitory sites of the calcium release channel ryano-
dine complex.
The organic mercurial compounds p-CMB and
4-CMPS interact with sulfhydryl groups of proteins.
The mercaptide complex (mercuri-thiol bonds)
formed by binding of p-CMB or 4-CMPS to sulf-
hydryl ligands is a reversible complex in the presence
of speci¢c thiol-reducing agents such as DTT [33^
36]. 4-CMPS is not a completely speci¢c modulator
of sulfhydryl groups, but may bind to glutamyl, or
histidyl residues at high concentrations [34]. DTT
reduced the 4-CMPS-induced increase in the open
probability in single channel recordings of the puri-
¢ed calcium release channel at subactivating, activat-
ing or inhibitory calcium concentrations, partially
inhibited the 4-CMPS-induced calcium release from
HSR vesicles and prevented the 4-CMPS-induced in-
crease in [3H]ryanodine binding to HSR vesicles.
These ¢ndings strongly suggest that the drug e¡ect
occurred, at least predominantly, through sulfhydryl
ligand binding to the calcium release channel protein.
From the data on activation of [3H]ryanodine
binding by increasing drug concentrations with Hill
coe⁄cients of 1.7^2.0 it appears that at least two
drug molecules must be bound to the calcium release
channel for activation. Since the activating e¡ect of
4-CMPS on [3H]ryanodine binding is completely
blocked by DTT, it is postulated that the modulation
of at least two sulfhydryl groups of the calcium re-
lease channel is essential for activation of
[3H]ryanodine binding and activation of the calcium
release channel. The stimulatory e¡ect of 4-CMPS on
[3H]ryanodine binding declined with increasing
4-CMPS concentrations and the binding reached lev-
els below controls; this e¡ect occurred in all individ-
ual experiments over a small concentration range.
Inhibition of [3H]ryanodine binding by 4-CMPS
(carried out in the presence of 100 WM Ca2,
10 WM [3H]ryanodine, 500 mM CsCl and 1^400
WM 4-CMPS) occurred with a Hill coe⁄cient of
5.49 þ 0.18 (means þ S.E.M.; n = 3). This ¢nding in-
dicates that modi¢cation of additional sulfhydryls
essential for the gating of the calcium release channel
(possibly more than ¢ve) is responsible for the switch
of the channel from a high to a low activity state, as
observed in single channel recordings by 100 WM
4-CMPS within 1 min. Alternatively, 4-CMPS may
modify other residues, as mentioned above. Di¡erent
classes of sulfhydryls of the calcium release channel
have been postulated recently following alkylation of
the calcium release channel of skeletal muscle HSR
by N-ethylmaleimide [17]. Di¡erent sulfhydryls in-
volved in activation and inhibition of the calcium
release channel have been postulated from single
channel studies of the cardiac calcium release chan-
nel following modulation by dithiodipyridine [37].
Activation of the calcium release channel by
p-CMB or 4-CMPS in the single channel experiments
occurred at subactivating (20 nM), maximally acti-
vating calcium concentrations (20^100 WM) and in-
hibitory calcium concentrations (1^4 mM). The max-
imum CMPS/CMB-induced increase in the open
probability at subactivating calcium concentrations
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was less than observed with the same channels at
maximally activating calcium concentrations. The in-
crease in the open probability of the calcium release
channel by 4-CMPS at subactivating calcium concen-
trations is in good agreement with the calcium e¥ux
from passively loaded HSR vesicles at the same low
free calcium concentration of 20 nM. In the calcium
release experiments concentrations of 30 and 100 WM
4-CMPS caused a rapid release of calcium from pas-
sively calcium-loaded HSR vesicles. The ruthenium
red sensitivity of the 4-CMPS-induced calcium e¥ux
strongly suggests that the stimulated calcium e¥ux
occurred via activation of the calcium release chan-
nel, as observed in single channel recordings. The
half-times of the 4-CMPS-induced biphasic calcium
release for the two release phases are similar to those
reported previously for the ca¡eine-induced calcium
release from passively loaded HSR vesicles at a sub-
activating calcium concentration of 50 nM [27]. A
fast rate of modi¢cation of the calcium release chan-
nel by high concentrations of 4-CMPS (100 WM) was
seen in the calcium release experiments (Fig. 11) per-
formed with the Bio-Logic rapid-¢ltration system,
whereas activation of the calcium release channel
by high concentrations of 4-CMPS was observed
30^45 s after addition of the compound. In single
channel experiments the mercury compounds were
added with a pipette to the cis solution and mixed
with a magnetic stirrer. The slower onset of activa-
tion in single channel recordings by high concentra-
tions of 4-CMPS (Figs. 2 and 4) is most probably
due to the slow rate of distribution of added agents
in single channel experiments, which does not allow
us to determine the actual rate of modi¢cation of
sulfhydryl groups.
At maximally activating calcium concentrations
4-CMPS or p-CMB caused a dramatic increase in
the open probability (about 0.9) of the calcium re-
lease channel (Figs. 3^5; Table 1A,B). The increase
in Po was characterized by an increase in the open
times of the calcium release channel. At inhibitory
calcium concentrations 4-CMPS shifted the inhibi-
tion of calcium to higher calcium concentrations
(Fig. 7). Activation (and inhibition) of the calcium
release channel by 4-CMPS occurred solely from the
cis side, whilst addition on the trans side had no
e¡ect.
The results of [3H]ryanodine binding to HSR
vesicles support the data from single channel experi-
ments. The [3H]ryanodine binding data demonstrate
an increase in the apparent a⁄nity of the high a⁄n-
ity calcium activation sites and an increase in the
apparent a⁄nity of [3H]ryanodine to the release
channel (Fig. 10, Table 3). The two- to four-fold
increase in the speci¢c [3H]ryanodine binding at
4 WM free calcium (Fig. 8, Table 2) is mainly due
to an increase in the apparent a⁄nity of the high
a⁄nity calcium activation sites. The signi¢cant in-
crease in the apparent Ka values due to 4-CMPS
was similar to that observed with ca¡eine. The in-
crease in [3H]ryanodine binding by ca¡eine and the
ca¡eine-induced increase in the apparent a⁄nity of
the high a⁄nity calcium activation sites are well
known [38^41]. The [3H]ryanodine binding data
show a decrease in the apparent a⁄nity of the low
a⁄nity calcium inhibitory sites in the presence of
10 WM 4-CMPS. The signi¢cant increase in the ap-
parent Ki values by 4-CMPS in [3H]ryanodine bind-
ing compared with the controls corresponds well
with the shift of the inhibitory e¡ect of calcium to
higher calcium concentrations seen in single channel
recordings. This e¡ect of 4-CMPS on [3H]ryanodine
binding was di¡erent from the e¡ect of ca¡eine [41]
or ca¡eine-like compounds, i.e. the 5 kDa peptide
imperatoxin increased the a⁄nity of calcium for
the high a⁄nity calcium binding sites in single chan-
nel recordings and [3H]ryanodine binding, but had
no e¡ect on the low a⁄nity calcium binding sites
[42].
High concentrations of 4-CMPS caused a rapid
initial activation, followed by an inhibition of the
calcium release channel. This observation con¢rms
the reported transient activation of single channel
£uctuations with frog HSR seen at high concentra-
tions of 4-CMPS [21]. The decrease in Po was char-
acterized by prolonged closed times of the calcium
release channel. The discrepancy between activation
in single channel recordings and activation of calci-
um release, but reduction in [3H]ryanodine binding
in the presence of 100 WM 4-CMPS is most likely due
to the short, transient activation of the calcium re-
lease channel. [3H]Ryanodine binding measures func-
tional alterations of the ryanodine receptor only on a
low time scale. Thus the reduced [3H]ryanodine bind-
ing re£ects most likely the low activity state in single
channel recordings induced by high 4-CMPS concen-
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trations, which is di¡erent from the activated high
activity state. This is also demonstrated by the fact
that the ca¡eine-stimulated [3H]ryanodine binding is
abolished in the presence of high concentrations of
4-CMPS.
In conclusion, the data on single channel record-
ings with the puri¢ed calcium release channel at sub-
activating, activating and inhibitory calcium concen-
trations and [3H]ryanodine binding to HSR con¢rm
that the 4-CMPS-induced activation of the calcium
release channel is due to a modulation of essential
sulfhydryls involved in the gating of the calcium re-
lease channel. This modulation of sulfhydryls was
associated with alterations of the apparent calcium
a⁄nity of the activating high a⁄nity calcium binding
sites as well as the inactivating low a⁄nity calcium
binding sites of the calcium release channel. The
modulation of the calcium release channel following
modi¢cation of essential sulfhydryls could either be
due to a direct alteration of the activating high a⁄n-
ity and inhibitory low a⁄nity calcium binding sites
of the calcium release channel or alternatively result
from a long-range allosteric e¡ect.
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